4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000239
EVP and CMO sold 596 shares at $482.50 ($287,570)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bozic Carmen · EVP and CMO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-26 | Sale : show line 1 in the form 10b5-1 | −596 | $482.50 | $287,570 | 15,337 | D |
| Open-market sales · 596 sh · avg $482.50 · $287,570 | ||||||
Loading xslF345X06/wk-form4_1782850180.xml…